UAB To Test Potential COVID-19 Vaccine
By BirminghamWatch
The University of Alabama at Birmingham and the biopharmaceutical company Altimmune Inc. will test a potential vaccine for COVID-19, the university announced today.
Testing of the vaccine, AdCOVID, which was developed by the company based in Gaithersburg, Maryland, will begin in mice during the second quarter of this year. That phase of testing, designed to show the immune response to the drug in mice, is expected to take one to two months, UAB said in announcing the collaboration.
The vaccine is given in a single dose of intranasal spray, UAB said. If results of the tests in mice warrant, Altimmune could launch a Phase 1 human safety trial during the third quarter of this year.
The announcement by UAB said Altimmune “has significant experience in the development of intranasal vaccine candidates for respiratory pathogens, including a seasonal and pandemic influenza vaccine and a vaccine for inhalation anthrax.”
“We are eager to collaborate with Altimmune on this important project,” said Frances E. Lund, the Charles H. McCauley Professor and Chair for the UAB Department of Microbiology. “The expertise and infrastructure at UAB will be invaluable to the rapid progression of this vaccine into clinical studies.
Lund said six labs at UAB will work on the project.
Vipin K. Garg, president and CEO of Altimmune, cited UAB’s role in research in virology and immunology. He said the company was founded through a technology license from UAB in 1997.
“It is critical that the biotechnology industry and academic institutions work together to prevent the further spread of COVID-19, and UAB is an ideal partner to support us in this effort,”Garg said.
UAB also has extensive experience in conducting clinical studies of vaccines and has participated in studies sponsored by the Vaccine Evaluation and Trial Unit, part of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.
The vaccine being tested “will activate mucosal and cellular immune responses, as well as a strong antibody response in the blood,” the announcement said.
“If the AdCOVID vaccine candidate is as stable as Altimmune’s influenza and anthrax vaccines candidates, that may allow inexpensive and efficient distribution of the millions of doses needed for widespread vaccination of populations,” the statement said.
Tributes, not politics, play center stage as Trump hosts the Kennedy Center Honors
President Trump said he was closely involved with picking the honorees, and on Sunday he became the first president to host the Kennedy Center awards ceremony.
Thailand launches airstrikes along border with Cambodia as tensions reignite
Both sides accused the other of breaking a ceasefire that halted fighting earlier this year. Longstanding border disputes erupted into five days of combat in July that killed dozens.
Rafael Ithier, a legend of salsa music, dies at 99
The pianist, composer and arranger spent more than six decades turning El Gran Combo into one of the premier salsa institutions of Latin America and beyond.
Light from satellites will ruin majority of some space telescope images, study says
Astronomers have long been concerned about reflections from satellites showing up in images taken by telescopes and other scientific instruments.
Defense Department is reviewing boat strike video for possible release, Hegseth says
In a speech on Saturday, Defense Secretary Pete Hegseth defended the strikes, saying: "President Trump can and will take decisive military action as he sees fit to defend our nation's interests."
Bama, Miami in, Notre Dame out and Indiana No. 1 in College Football Playoff rankings
Nobody paying attention for the past 24 months would be surprised to see Indiana – yes, Indiana – leading the way into this year's College Football Playoff.
